RHYTHM PHARMACEUTICALS

rhythm-pharmaceuticals-logo

Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics for the treatment of rare genetic deficiencies that result in life-threatening metabolic disorders. Their lead peptide product candidate, setmelanotide, is a potent, first-in-class melanocortin-4 receptor (MC4R) agonist for the treatment of rare genetic disorders of obesity. They believe that setmelanotide, for which they have exclusive worldwide rights, has the potential to serve as replacement therapy for the treatment of melanocortin 4, or MC4, pathway deficiencies. The MC4 pathway is a compelling target for treating these genetic disorders because of its critical role in regulating appetite and weight, and peptide therapeutics are uniquely suited to activating this target.

#People #Financial #Event #Website #More

RHYTHM PHARMACEUTICALS

Social Links:

Industry:
Biotechnology Pharmaceutical Therapeutics

Founded:
2010-02-01

Address:
Boston, Massachusetts, United States

Country:
United States

Website Url:
http://www.rhythmtx.com

Total Employee:
101+

Status:
Active

Total Funding:
637.7 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics



Current Advisors List

elizabeth-stoner_image

Elizabeth Stoner Senior Clinical Advisor @ Rhythm Pharmaceuticals
Advisor
2010-01-01

steven-peter_image

Steven Peter Board Member @ Rhythm Pharmaceuticals
Board_member

ed-mathers_image

Ed Mathers Board Member @ Rhythm Pharmaceuticals
Board_member

Current Employees Featured

david-connolly_image

David Connolly
David Connolly Head of Investor Relations and Corporate Communications @ Rhythm Pharmaceuticals
Head of Investor Relations and Corporate Communications
2019-05-01

michelle-hylan_image

Michelle Hylan
Michelle Hylan Clinical Consultant @ Rhythm Pharmaceuticals
Clinical Consultant
2014-06-01

hunter-smith_image

Hunter Smith
Hunter Smith Chief Financial Officer @ Rhythm Pharmaceuticals
Chief Financial Officer

pamela-cramer_image

Pamela Cramer
Pamela Cramer Chief Human Resources Officer @ Rhythm Pharmaceuticals
Chief Human Resources Officer

joe-shulman_image

Joe Shulman
Joe Shulman Chief Technical Officer @ Rhythm Pharmaceuticals
Chief Technical Officer
2022-02-01

linda-shapiro-manning_image

Linda Shapiro Manning
Linda Shapiro Manning Chief Medical Officer (CMO) @ Rhythm Pharmaceuticals
Chief Medical Officer (CMO)
2021-09-10

irene-aquino_image

Irene Aquino
Irene Aquino Vice President, Patient Advocacy and Customer Engagement @ Rhythm Pharmaceuticals
Vice President, Patient Advocacy and Customer Engagement
2021-02-01

jennifer-chien_image

Jennifer Chien
Jennifer Chien Executive Vice President, Head of North America @ Rhythm Pharmaceuticals
Executive Vice President, Head of North America
2020-11-01

patrick-kleyn_image

Patrick Kleyn
Patrick Kleyn SVP and Head of Translational Research and Development @ Rhythm Pharmaceuticals
SVP and Head of Translational Research and Development
2022-02-01

lex-ht-van-der-ploeg_image

Lex H.T. Van der Ploeg
Lex H.T. Van der Ploeg Consultant @ Rhythm Pharmaceuticals
Consultant
2019-07-01

Founder


bart-henderson_image

Bart Henderson

elizabeth-stoner_image

Elizabeth Stoner

Stock Details


Company's stock symbol is NASDAQ:RYTM

Investors List

healthcare-royalty-partners_image

HealthCare Royalty Partners

HealthCare Royalty Partners investment in Post-IPO Debt - Rhythm Pharmaceuticals

ipsen_image

Ipsen

Ipsen investment in Venture Round - Rhythm Pharmaceuticals

third-rock-ventures_image

Third Rock Ventures

Third Rock Ventures investment in Venture Round - Rhythm Pharmaceuticals

new-enterprise-associates_image

New Enterprise Associates

New Enterprise Associates investment in Venture Round - Rhythm Pharmaceuticals

orbimed-advisors_image

OrbiMed

OrbiMed investment in Venture Round - Rhythm Pharmaceuticals

deerfield-management_image

Deerfield Capital Management

Deerfield Capital Management investment in Venture Round - Rhythm Pharmaceuticals

mpm-capital_image

MPM Capital

MPM Capital investment in Venture Round - Rhythm Pharmaceuticals

pfizer-venture-investments_image

Pfizer Venture Investments

Pfizer Venture Investments investment in Venture Round - Rhythm Pharmaceuticals

new-enterprise-associates_image

New Enterprise Associates

New Enterprise Associates investment in Series A - Rhythm Pharmaceuticals

mpm-capital_image

MPM Capital

MPM Capital investment in Series A - Rhythm Pharmaceuticals

Official Site Inspections

http://www.rhythmtx.com Semrush global rank: 1.77 M Semrush visits lastest month: 13.17 K

  • Host name: 141.193.213.20
  • IP address: 141.193.213.20
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Rhythm Pharmaceuticals"

Homepage - Rhythm Pharmaceuticals

Rhythm Pharmaceuticals is a global biopharmaceutical company committed to transforming the lives of patients with rare neuroendocrine diseases by rapidly advancing care and precision …See details»

Homepage | Rhythm Corporate

Our expertise and close collaboration with patients, caregivers, and healthcare professionals enable us to understand the complex challenges of rare MC4R pathway diseases and identify …See details»

Leadership - Rhythm Pharmaceuticals

Rhythm is guided by strong leadership at every level. We share an unrelenting drive to develop new therapies for rare neuroendocrine diseases, offering hope to patients and their families. …See details»

About - Rhythm Pharmaceuticals

Rhythm was founded in 2008 in Boston. Our lead asset, IMCIVREE® (setmelanotide), FDA-approved in 2020, is a precision medicine designed to treat severe obesity caused by an …See details»

Rhythm Pharmaceuticals Inc. - LinkedIn

Rhythm is a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare MC4R pathway diseases.See details»

Homepage - Rhythm Pharmaceuticals HCP Site

We are committed to helping healthcare professionals understand, diagnose, and treat rare neuroendocrine diseases. A key neurosignaling pathway in the hypothalamus responsible for …See details»

Rhythm Pharmaceuticals - Crunchbase Company …

Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics for the treatment of rare genetic deficiencies that result in life-threatening metabolic disorders. Their lead peptide product …See details»

Pioneering Hyperphagia Care for MC4R Pathway Diseases

We’re dedicated to transforming the lives of patients and their families living with hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) pathway diseases by rapidly …See details»

Rhythm Pharmaceuticals is a biopharmaceutical company …

Rhythm Pharmaceuticals is advancing the clinical development program for setmelanotide, an MC4R agonist, as well as investigational MC4R agonists LB54640 and RM-718. In addition, …See details»

Release Details - Rhythm Pharmaceuticals, Inc.

BOSTON, July 23, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of …See details»

Patients - Rhythm Pharmaceuticals

Rhythm is deeply committed not only to developing medicines for rare neuroendocrine diseases, but also to helping patients with these diseases receive the education, awareness, and access …See details»

Release Details - ir.rhythmtx.com

BOSTON, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq:RYTM), a biopharmaceutical company aimed at developing and commercializing …See details»

Rhythm Pharmaceuticals Inc. Information - RocketReach

Rhythm Pharmaceuticals Inc. is a Biotechnology Research, Pharmaceuticals, and Healthcare company located in Boston, Massachusetts with $66.2 million in revenue and 272 employees. …See details»

Rhythm Pharmaceuticals appoints Board Chairman Dr David

Jul 20, 2020 Â· Rhythm is a late-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of rare genetic disorders of obesity.See details»

Rhythm Pharmaceuticals Announces Participation in Upcoming …

BOSTON, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the …See details»

Rhythm Pharmaceuticals, Inc. (RYTM) - Yahoo Finance

Find the latest Rhythm Pharmaceuticals, Inc. (RYTM) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»

Science - Rhythm Pharmaceuticals

At Rhythm, we are dedicated to discovering therapies for rare neuroendocrine diseases. Our science is focused on developing therapies for patients with hyperphagia (insatiable hunger) …See details»

Overview, News & Similar companies - ZoomInfo.com

Jun 11, 2024 Â· Rhythm Pharmaceuticals contact info: Phone number: (857) 264-4280 Website: www.rhythmtx.com What does Rhythm Pharmaceuticals do? Were dedicated to transforming …See details»

Careers - Rhythm Pharmaceuticals

At Rhythm, we know our work makes an important difference in the lives of patients and their families around the world. Every employee contributes to the company’s goal of discovering …See details»

RYTM Stock Price Quote | Morningstar

Nov 8, 2024 Â· See the latest Rhythm Pharmaceuticals Inc stock price (RYTM:XNAS), related news, valuation, dividends and more to help you make your investing decisions.See details»

linkstock.net © 2022. All rights reserved